New study aims to control blood sugar in diabetic pregnancies after preterm birth steroids

NCT ID NCT04542148

Ongoing Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the best way to control blood sugar in pregnant women with diabetes who receive steroids to help their baby's lungs develop before a possible early birth. About 120 women will be randomly assigned to one of three insulin strategies. The goal is to find which approach keeps blood sugar levels safest for both mother and baby.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes Premature Birth type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS (TYPE 2) DIABETES, GESTATIONAL PREGNANCY, HIGH RISK PRETERM BIRTH

Contacts and locations

Show contact details

Locations

Oregon Health and Science University

Portland, Oregon, 97239, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35223, United States
University of South Carolina Greenville / Prisma Health-Upstate

Greenville, South Carolina, 29605, United States
University of Texas Health Science Center at Houston

Houston, Texas, 77024, United States